Best Uterine Trachelectomy Doctors Worldwide — TOP 14

Dr. Jordi Antoni Vives is a specialist in gynecology and obstetrics at Teknogin (Centro Médico Teknon, Barcelona). He focuses on gynecologic oncology surgery, complex uterine and pelvic pathology, and tumor board coordination. He has led Obstetrics at Hospital CIMA since 2015. He has been a consultant physician at Parc Taulí since 1990.

Education/accreditations: Degree in Medicine and Surgery, University of Barcelona (1983). MIR residency in Gynecology and Obstetrics (1990). European University Diploma in Operative Endoscopy in Gynecology, advanced level (2000). Da Vinci robotic surgery accreditation (2010). Training stays at Mayo Clinic, Scottsdale (1994 and 1999).

Leadership/memberships/awards: Coordinator and president of the Functional Unit of Gynecologic Oncology and the Tumor Committee at Parc Taulí. Member of the Spanish, Catalan, and European Societies of Gynecology and Obstetrics, and of the GEICO Cervical Cancer Committee. President of the collegiate section of Gynecology and Obstetrics at the Official College of Physicians of Barcelona. Professional Excellence Award (2015) and Top Doctors Awards 2016.

Dr. Rafal Kuzlik is a gynecologist and reconstructive surgeon at SaskaMed in Warsaw. He authored the internationally recognized One Cut, Linear Z, and Double O surgical techniques. These methods focus on aesthetic and functional gynecology. Dr. Kuzlik has performed approximately 10,000 operations. He practices in both Poland and Dubai.

• Developed original techniques for labiaplasty and clitoral repositioning.
• Served as former Head of Gynecology at EMC St. Anne’s Hospital.
• General Secretary of the World Academy of Regenerative and Aesthetic Gynecology.
• Trains physicians globally on surgical techniques in functional gynecology.

Dr. Yeoun E Park is the hospital director and Chief Medical Officer at Seoul Miz Hospital. She specializes in laparoscopic surgery for uterine fibroids and ovarian tumors. Dr. Park also manages the incontinence and women's cosmetic surgery clinics. She holds adjunct professor roles at Korea University and Hallym University medical colleges.

• Leads a facility that has performed 10,000+ treatments for fibroids and cysts.
• Expert in minimally invasive myomectomy and hysterectomy using the Da Vinci robotic system.
• Specializes in stress urinary incontinence with over 5,000 successful TOT procedures.
• Treats complex conditions including endometriosis, cervical dysplasia, and high-risk pregnancies.

The doctor is a highly experienced specialist in Obstetrics and Gynecology with over three decades of clinical practice. Since 1994, the doctor has been a key member of the medical faculty at Centro Médico Teknon in Barcelona, where the doctor currently serves as the Head of Service in Gynecology and Obstetrics. The doctor’s clinical focus encompasses infertility diagnosis, assisted reproduction techniques, IVF planning, comprehensive pregnancy monitoring, childbirth care, and prenatal diagnostics.

In addition to extensive expertise in gynecological ultrasound and menopause management, the doctor holds a Level III Training Diploma in Obstetric and Gynecologic Ultrasound from the Spanish Society of Obstetrics and Gynecology.

Op. Dr. Kevser Arkan, MD, is a gynecologic oncology surgery subspecialist (OB/GYN) at OPTIMED Health Group in Çorlu and Çerkezköy. She has worked there since 2026. She provides care in English and Turkish.

Her clinical focus is the surgical management of ovarian, endometrial, and cervical cancers. She performs complex pelvic procedures, including radical hysterectomy, lymphadenectomy with sentinel lymph node mapping, and tumor debulking. She offers minimally invasive surgery, including vNOTES (scarless/izsiz laparoskopi), laparoscopy, laparotomy, and hysteroscopy. She also performs urogynecologic reconstruction, including sacrocolpopexy. She manages high‑risk obstetrics.

Credentials: MD, Gaziantep University (2016). OB/GYN residency, Kahramanmaraş Sütçü İmam University (2016–2021). Gynecologic Oncology Surgery fellowship, Diyarbakır Gazi Yaşargil Training and Research Hospital (2022–2025). Experience: Diyarbakır Maternity & Children’s Hospital, Gynecologic Oncology Clinic (2022–2025). Adıyaman Kahta State Hospital (2021–2022). Giresun Alucra TSM (2016).

Academic work: In 2025, she published peer‑reviewed studies on sentinel node mapping in vNOTES endometrial cancer staging and on outcomes of vNOTES versus laparoscopy. She also reported on pelvic organ prolapse and sexual function, GTN folate regimens, and vNOTES‑assisted sacrocolpopexy. Her articles appeared in journals such as BMC Surgery, Scientific Reports, Journal of Clinical Medicine, and Ginekologia Polska.

Dr. Lan Kerdpol specializes in reproductive health and gynecological surgeries at Navamin 9 Hospital in Bangkok.

• Certified by the Thai Board of Obstetrics and Gynecology
• Trained at Mahidol University, renowned for its medical program
• Expertise includes antenatal care and complex gynecological procedures

Dr. Doyoung Jeong is an obstetrician-gynecologist at Seoul Miz Hospital. He specializes in single-port robotic and minimally invasive surgery for uterine and ovarian diseases. Dr. Jeong holds multiple patents for specialized single-port surgical devices. He is a full member of the International Society of Ultrasound in Obstetrics and Gynecology.

• Served as Director and Chief Medical Officer at Incheon Sejong Hospital.
• Former Vice President at Dongtan Jeil Hospital.
• Clinical Professor at Kyung Hee University Hospital and Adjunct Professor at Korea University.
• Acts as a clinical medical device expert for the Ministry of Food and Drug Safety.

Dr. Roy Mashiach is the Director of Gynecology at Sheba Medical Center in Israel. He specialized in minimally invasive gynecologic surgery and fertility-preserving procedures. Dr. Mashiach received the Daniel F. Kott Award for surgical innovation from the AAGL.

• Serves as the Chairman of the Israeli Society of Gynecological Endoscopy.
• Consistently named among the Best Doctors in Israel by Forbes.
• Specializes in laparoscopic hysterectomy and robot-assisted myoma removal.
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.